NSL Group Limited
Registered name: NSL GROUP LIMITED
NSL Group Limited made £0 revenue and a £1.1k loss in the year to 31 Oct 2025. read from filing text
NSL Group Limited’s revenue was £0 in the year to 31 Oct 2025, with a loss of £1.1k and 2 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Northolt; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Northolt, London
- Age
- 18 yrs · since 2008
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The company is under the common control of the directors, Mr K Mehta and Mr B Mehta, who are”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Oct 2022 | 31 Oct 2023 | 31 Oct 2024 | 31 Oct 2025 |
|---|---|---|---|---|
| Disclosure | Profit only | Full P&Lread from filing text | Full P&Lread from filing text | Full P&Lread from filing text |
| Profit & loss | ||||
| Revenue (turnover) | — | £0 | £0 | £0 |
| Operating profit | — | −£1.4k | −£1.4k | — |
| Profit before tax | −£1.1k | −£1.5k | −£1.4k | −£1.4k |
| Profit after tax | −£906 | £596 | −£1k | −£1.1k |
| Profit (best available) | −£906 | £596 | −£1k | −£1.1k |
| Employees (average) | 2 | 2 | 2 | 2 |
| Ratios | ||||
| Profit margin | — | — | — | — |
| Revenue per employee | — | £0 | £0 | £0 |
| Profit per employee | −£453 | £298 | −£518 | −£526 |
| Growth (year on year) | ||||
| Profit growth | — | — | ▼274% | — |
| Headcount growth | — | 0% | 0% | 0% |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £4 | £0 | £9 | £0 |
| Net assets | £11.5m | £8.5m | £8.5m | £8.5m |
| Current assets | £3m | £12.7k | £13.1k | £13.4k |
| Debtors | £3m | £12.7k | £13k | £13.4k |
| Deferred income | £7.3k | £7.3k | £7.3k | £8.5k |
| Cash from operations | £0 | −£2.6m | £1.4k | £154 |
| Source | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Aug 2025 | FullAccounts · bulk data Jul 2026 |
How the business works
- Profit margin
- —
- Profit ÷ revenue.
- Gross margin
- —
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £0
- Revenue ÷ average employees.
- Profit per employee
- −£526
- Profit ÷ average employees.
- Cash conversion
- —
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- —
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▼0%
- Now £8.5m
- Cash at bank
- ▼100%
- Now £0
- Headcount
- 0%
- Now 2
- Deferred income
- ▲17%
- Now £8.5k
- Fixed assets
- —
- Now —
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Similar profitable businesses
- Aspire Pharma LimitedGodalming · Wholesale of pharmaceutical goods
- Revenue
- £118m
- Profit
- £21.8m
- Staff
- 114
- Day Lewis Medical LimitedCroydon · Wholesale of pharmaceutical goods
- Revenue
- £281m
- Profit
- £14m
- Staff
- 241
- Adelphi (Tubes) LimitedHaywards Heath · Wholesale of pharmaceutical goods
- Revenue
- £29.6m
- Profit
- £8.7m
- Staff
- 31
- Smartway Pharmaceuticals LimitedLeicester · Wholesale of pharmaceutical goods
- Revenue
- £177m
- Profit
- £8m
- Staff
- 103
- Drugsrus LimitedHarrow · Wholesale of pharmaceutical goods
- Revenue
- £55.6m
- Profit
- £6.3m
- Staff
- 105
- Trion Pharma LimitedCoventry · Wholesale of pharmaceutical goods
- Revenue
- £19.2m
- Profit
- £6.2m
- Staff
- 18
Sources
Latest figures from FullAccounts for the year to 31 Oct 2025 (profit −£1.1k), from the Companies House accounts bulk data published Jul 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.